Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1979 1
1984 1
1987 1
1997 2
1998 1
1999 1
2000 1
2002 1
2003 1
2004 2
2005 6
2006 3
2010 1
2011 5
2012 8
2013 5
2014 8
2015 8
2016 5
2017 7
2018 9
2019 8
2020 6
2021 8
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for kirsch, b
Search for Kireche B instead (2 results)
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators. Hart RG, et al. Among authors: kirsch b. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766772 Free article. Clinical Trial.
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Shoamanesh A, Mundl H, Smith EE, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas JL, Dong Q, Turcani P, Christensen H, Ferro JM, Veltkamp R, Mikulik R, De Marchis GM, Robinson T, Lemmens R, Stepien A, Greisenegger S, Roine R, Csiba L, Khatri P, Coutinho J, Lindgren AG, Demchuk AM, Colorado P, Kirsch B, Neumann C, Heenan L, Xu L, Connolly SJ, Hart RG; PACIFIC-Stroke Investigators. Shoamanesh A, et al. Among authors: kirsch b. Lancet. 2022 Sep 24;400(10357):997-1007. doi: 10.1016/S0140-6736(22)01588-4. Epub 2022 Sep 2. Lancet. 2022. PMID: 36063821 Clinical Trial.
Non-Hodgkin Lymphoma Metabolism.
Kirsch BJ, Chang SJ, Betenbaugh MJ, Le A. Kirsch BJ, et al. Adv Exp Med Biol. 2021;1311:103-116. doi: 10.1007/978-3-030-65768-0_7. Adv Exp Med Biol. 2021. PMID: 34014537 Free PMC article.
Non-Hodgkin Lymphoma Metabolism.
Kirsch BJ, Chang SJ, Le A. Kirsch BJ, et al. Adv Exp Med Biol. 2018;1063:95-106. doi: 10.1007/978-3-319-77736-8_7. Adv Exp Med Biol. 2018. PMID: 29946778 Review.
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Rao SV, Kirsch B, Bhatt DL, Budaj A, Coppolecchia R, Eikelboom J, James SK, Jones WS, Merkely B, Keller L, Hermanides RS, Campo G, Ferreiro JL, Shibasaki T, Mundl H, Alexander JH; PACIFIC AMI Investigators. Rao SV, et al. Among authors: kirsch b. Circulation. 2022 Oct 18;146(16):1196-1206. doi: 10.1161/CIRCULATIONAHA.122.061612. Epub 2022 Aug 27. Circulation. 2022. PMID: 36030390 Clinical Trial.
Training the Next Generation of Innovators in Dermatology.
Xu S, Allred J, Kirsch B, Raff A, Anderson RR, Ju W. Xu S, et al. Among authors: kirsch b. J Invest Dermatol. 2016 Nov;136(11):2113-2115. doi: 10.1016/j.jid.2016.08.028. J Invest Dermatol. 2016. PMID: 27772542 Free article. No abstract available.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Free article. Clinical Trial.
A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation.
Shimshak SJE, Tolaymat LM, Haga CB, Dawson NL, Gillis MS, Yin M, Kirsch B, Cooper M, Sluzevich JC. Shimshak SJE, et al. Among authors: kirsch b. J Cutan Med Surg. 2022 Mar-Apr;26(2):169-175. doi: 10.1177/12034754211045391. Epub 2021 Sep 19. J Cutan Med Surg. 2022. PMID: 34541912 Review.
Methodological Problems With Online Concussion Testing.
Holden J, Francisco E, Tommerdahl A, Lensch R, Kirsch B, Zai L, Pearce AJ, Favorov OV, Dennis RG, Tommerdahl M. Holden J, et al. Among authors: kirsch b. Front Hum Neurosci. 2020 Oct 1;14:509091. doi: 10.3389/fnhum.2020.509091. eCollection 2020. Front Hum Neurosci. 2020. PMID: 33132870 Free PMC article.
100 results